Olumiant becomes the first oral medicine to bag approval by the Food and Drug Administration as a treatment for severe
Continue readingCategory: Pharma
Weekly Snapshot of Top Trends in the HLS Industry
These are the weekly disruptions seen in the healthcare industry from last week (6th June to 13 June).
Continue readingFDA considers Pfizer-BioNTech safe and effective for children under 5 years
The Food and Drug Administration (FDA) staff said that the vaccine manufactured by Pfizer and BioNTech is safe to be
Continue readingCanadian government will purchase Bavarian Nordic’s smallpox vaccine
The Public Health Agency of Canada (PHAC) has entered into a five-year contract with Bavarian Nordic for the purchase of
Continue readingAstraZeneca and Daiichi Sankyo’s drug shows promising results for breast cancer
AstraZeneca and Daiichi Sankyo’s HER2-targeting drug ‘Enhertu’ may be the answer to HER2-low breast cancers.
Continue readingWeekly Snapshot of Top Trends in the HLS Industry
These are the weekly disruptions seen in the healthcare industry from last week (30 May to 6th June).
Continue readingUCB’s Fintepla nabs recommendations from NICE for Dravet Syndrome
National Institute for Healthcare Excellence (NICE) has recommended Fintepla, an oral drug manufactured by the biopharmaceutical firm UCB, for Dravet
Continue readingZuranolone shows promising results for postpartum depression
Zuranolone is an investigational drug that showed evidence in the phase 3 SKYLARK study for the treatment of postpartum depression
Continue readingWeight loss drug Ozempic on shortage after promoted by TikTok users for weight loss
Ozempic, a drug used to treat diabetes, is on shortage due to high consumer demands after it goes viral on
Continue readingDrug-Resistant tuberculosis may have a treatment from new class of antibiotic
A study published in the journal PLOS Biology by Ho-Yeon Song of Soonchunhyang University in the Republic of Korea informs
Continue reading
English